Improving children's medicines
- 14 June 2005
- journal article
- editorial
- Published by BMJ in Archives of Disease in Childhood
- Vol. 91 (7) , 550-551
- https://doi.org/10.1136/adc.2006.094805
Abstract
It is reassuring that the majority of Scottish paediatricians are aware of the concept of off label prescribing (p XXX).1 The term off label relates to the use of a medicine in a manner different from that recommended by the manufacturers in their product licence.2 A formal classification system for the different types of off label and unlicensed drug use was described in 1997. In a period of a few years, several studies confirmed that off label drug prescribing was a significant problem in children in hospital,3 in neonates,4 and in primary care.5Keywords
This publication has 11 references indexed in Scilit:
- A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatriciansArchives of Disease in Childhood, 2005
- Training in paediatric clinical pharmacology in the UKBritish Journal of Clinical Pharmacology, 2004
- Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished dataThe Lancet, 2004
- Pediatric Drug LabelingJAMA, 2003
- FDAMA's written request list: medicines for childrenThe Lancet, 2001
- Unlicensed and off label prescribing of drugs in general practiceArchives of Disease in Childhood, 2000
- Survey of unlicensed and off label drug use in paediatric wards in European countriesBMJ, 2000
- Closing the gap in drug therapyThe Lancet, 1999
- Unlicensed and off label drug use in neonates CommentaryArchives of Disease in Childhood: Fetal & Neonatal, 1999
- Unlicensed and off label drug use in paediatric wards: prospective studyBMJ, 1998